Cargando…

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects

PURPOSE: There are already numerous reports about high local control rates in patients with craniopharyngioma but there are only few studies with follow up times of more than 10 years. This study is an analysis of long term control, tumor response and side effects after fractionated stereotactic rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrabi, Semi B, Adeberg, Sebastian, Welzel, Thomas, Rieken, Stefan, Habermehl, Daniel, Debus, Jürgen, Combs, Stephanie E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261584/
https://www.ncbi.nlm.nih.gov/pubmed/25227427
http://dx.doi.org/10.1186/1748-717X-9-203
_version_ 1782348298418388992
author Harrabi, Semi B
Adeberg, Sebastian
Welzel, Thomas
Rieken, Stefan
Habermehl, Daniel
Debus, Jürgen
Combs, Stephanie E
author_facet Harrabi, Semi B
Adeberg, Sebastian
Welzel, Thomas
Rieken, Stefan
Habermehl, Daniel
Debus, Jürgen
Combs, Stephanie E
author_sort Harrabi, Semi B
collection PubMed
description PURPOSE: There are already numerous reports about high local control rates in patients with craniopharyngioma but there are only few studies with follow up times of more than 10 years. This study is an analysis of long term control, tumor response and side effects after fractionated stereotactic radiotherapy (FSRT) for patients with craniopharyngioma. PATIENTS AND METHODS: 55 patients who were treated with FSRT for craniopharyngioma were analyzed. Median age was 37 years (range 6–70 years), among them eight children < 18 years. Radiotherapy (RT) was indicated for progressive disease after neurosurgical resection or postoperatively after repeated resection or partial resection. A median dose of 52.2 Gy (50 – 57.6 Gy) was applied with typical dose per fraction of 1.8 Gy five times per week. The regular follow up examinations comprised in addition to contrast enhanced MRI scans thorough physical examinations and clinical evaluation. RESULTS: During median follow up of 128 months (2 – 276 months) local control rate was 95.3% after 5 years, 92.1% after 10 years and 88.1% after 20 years. Overall survival after 10 years was 83.3% and after 20 years 67.8% whereby none of the deaths were directly attributed to craniopharyngioma. Overall treatment was tolerated well with almost no severe acute or chronic side effects. One patient developed complete anosmia, another one’s initially impaired vision deteriorated further. In 83.6% of the cases with radiological follow up a regression of irradiated tumor residues was monitored, in 7 cases complete response was achieved. 44 patients presented themselves initially with endocrinologic dysfunction none of them showed signs of further deterioration during follow up. No secondary malignancies were observed. CONCLUSION: Long term results for patients with craniopharyngioma after stereotactic radiotherapy are with respect to low treatment related side effects as well as to local control and overall survival excellent.
format Online
Article
Text
id pubmed-4261584
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42615842014-12-10 Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects Harrabi, Semi B Adeberg, Sebastian Welzel, Thomas Rieken, Stefan Habermehl, Daniel Debus, Jürgen Combs, Stephanie E Radiat Oncol Research PURPOSE: There are already numerous reports about high local control rates in patients with craniopharyngioma but there are only few studies with follow up times of more than 10 years. This study is an analysis of long term control, tumor response and side effects after fractionated stereotactic radiotherapy (FSRT) for patients with craniopharyngioma. PATIENTS AND METHODS: 55 patients who were treated with FSRT for craniopharyngioma were analyzed. Median age was 37 years (range 6–70 years), among them eight children < 18 years. Radiotherapy (RT) was indicated for progressive disease after neurosurgical resection or postoperatively after repeated resection or partial resection. A median dose of 52.2 Gy (50 – 57.6 Gy) was applied with typical dose per fraction of 1.8 Gy five times per week. The regular follow up examinations comprised in addition to contrast enhanced MRI scans thorough physical examinations and clinical evaluation. RESULTS: During median follow up of 128 months (2 – 276 months) local control rate was 95.3% after 5 years, 92.1% after 10 years and 88.1% after 20 years. Overall survival after 10 years was 83.3% and after 20 years 67.8% whereby none of the deaths were directly attributed to craniopharyngioma. Overall treatment was tolerated well with almost no severe acute or chronic side effects. One patient developed complete anosmia, another one’s initially impaired vision deteriorated further. In 83.6% of the cases with radiological follow up a regression of irradiated tumor residues was monitored, in 7 cases complete response was achieved. 44 patients presented themselves initially with endocrinologic dysfunction none of them showed signs of further deterioration during follow up. No secondary malignancies were observed. CONCLUSION: Long term results for patients with craniopharyngioma after stereotactic radiotherapy are with respect to low treatment related side effects as well as to local control and overall survival excellent. BioMed Central 2014-09-16 /pmc/articles/PMC4261584/ /pubmed/25227427 http://dx.doi.org/10.1186/1748-717X-9-203 Text en © Harrabi et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Harrabi, Semi B
Adeberg, Sebastian
Welzel, Thomas
Rieken, Stefan
Habermehl, Daniel
Debus, Jürgen
Combs, Stephanie E
Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
title Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
title_full Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
title_fullStr Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
title_full_unstemmed Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
title_short Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
title_sort long term results after fractionated stereotactic radiotherapy (fsrt) in patients with craniopharyngioma: maximal tumor control with minimal side effects
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261584/
https://www.ncbi.nlm.nih.gov/pubmed/25227427
http://dx.doi.org/10.1186/1748-717X-9-203
work_keys_str_mv AT harrabisemib longtermresultsafterfractionatedstereotacticradiotherapyfsrtinpatientswithcraniopharyngiomamaximaltumorcontrolwithminimalsideeffects
AT adebergsebastian longtermresultsafterfractionatedstereotacticradiotherapyfsrtinpatientswithcraniopharyngiomamaximaltumorcontrolwithminimalsideeffects
AT welzelthomas longtermresultsafterfractionatedstereotacticradiotherapyfsrtinpatientswithcraniopharyngiomamaximaltumorcontrolwithminimalsideeffects
AT riekenstefan longtermresultsafterfractionatedstereotacticradiotherapyfsrtinpatientswithcraniopharyngiomamaximaltumorcontrolwithminimalsideeffects
AT habermehldaniel longtermresultsafterfractionatedstereotacticradiotherapyfsrtinpatientswithcraniopharyngiomamaximaltumorcontrolwithminimalsideeffects
AT debusjurgen longtermresultsafterfractionatedstereotacticradiotherapyfsrtinpatientswithcraniopharyngiomamaximaltumorcontrolwithminimalsideeffects
AT combsstephaniee longtermresultsafterfractionatedstereotacticradiotherapyfsrtinpatientswithcraniopharyngiomamaximaltumorcontrolwithminimalsideeffects